ProfileGDS5822 / ILMN_1229433
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 68% 69% 55% 62% 67% 66% 65% 59% 57% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 144.168
GSM1276600PDAC Late Ablation Control 251.769
GSM1276601PDAC Late Ablation Control 326.155
GSM1276602PDAC Late Ablation 128.462
GSM1276603PDAC Late Ablation 24467
GSM1276604PDAC Late Ablation 344.266
GSM1303940PDAC Late Ablation_anti-CTLA4 134.265
GSM1303941PDAC Late Ablation_anti-CTLA4 234.459
GSM1303942PDAC Late Ablation_anti-CTLA4 333.457